Peddock Capital Advisors, LLC Mannkind Corp Transaction History

Peddock Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.14 - $6.14 $628 - $1,228	-200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $358 - $808	200 New	200 $1,000
Q1 2020 May 13, 2020	SELL	$0.84 - $1.76 $168 - $352	-200 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$1.14 - $1.49 $227 - $298	200 New	200 $0
Q2 2019 Aug 06, 2019	SELL	$1.09 - $1.88 $218 - $376	-200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $229 - $458	200	200 $0

220

133M

1.43M

851K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.67B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Peddock Capital Advisors, LLC with notifications on news.